Bayer and Blackford Analysis develop an intelligent platform for radiology

German pharmaceutical company Bayer has teamed up with Scottish artificial intelligence
Blackford
signed an agreement to develop an intelligent platform for medical imaging.The two companies have reached an agreement to develop and license an intelligent platform for radiology suites that integrate intelligent applications into medical imaging workflows.
The new platform will be designed to support radiologists' decision-making processes and improve diagnostic confidence.Bayer and Blackwood's smart platform will be developed to provide access toVirtual Market , which will allow healthcare professionals to access and manage diagnostic imaging analytics applications, protocol management tools, department workflow tools, and intelligent algorithms.Under the terms of
agreement,
will develop and deliver platform technology for Bayer. Bayer will then provide integrated intelligent solutions developed in-house, in collaboration with third parties, and will also contribute to its medical and data science capabilities and a deep understanding of disease.“
Our
with Blackford Analysis
strengthens our commitment to innovation in medical imaging. We want to increase clinical value by supporting radiologists and their teams to provide clear guidance from diagnosis to care to drive radiation solutions with AI value.
,"
, head of digital business solutions for radiology at Bayer,
, said
Salvador.He added:
"
we look forward to combining our long-term knowledge and radiological expertise in the life sciences with the technical and development capabilities of
Blackford Analytics
."
"
(
cyy123.com
):
Bayer inks deal with Blackford Analysis to develop radiology Aiplatform